Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
about
Burkitt lymphoma in adolescents and young adults: management challenges.Mature aggressive B-cell lymphoma across age groups - molecular advances and therapeutic implications.Treating adults with acute lymphocytic leukemia: new pharmacotherapy options.Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survivalCentral nervous system involvement in AIDS-related lymphomasNew insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia.A review of rituximab, the first anti-CD20 monoclonal antibody used in the treatment of B non-Hodgkin's lymphomas.Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemiaHSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.Recent molecular and therapeutic advances in B-cell non-Hodgkin lymphoma in children.Adolescent and young adult non-Hodgkin lymphoma.Novel Therapeutic Strategies in Acute Lymphoblastic Leukemia.Childhood, adolescent and young adult non-Hodgkin lymphoma: state of the science.Human lymphocytic B-leukemia cell line treatment with the bacterial toxin listeriolysin O and rituximab (anti-CD20 antibody): Effects of similar localization of their receptors.A novel approach to detect resistance mechanisms reveals FGR as a factor mediating HDAC inhibitor SAHA resistance in B-cell lymphoma.Burkitt leukemia limited to the bone marrow has a better prognosis than Burkitt lymphoma with bone marrow involvement in adults.Peripheral blood lymphocyte to monocyte ratio identifies high-risk adult patients with sporadic Burkitt lymphoma.Personalized medicine in adult acute lymphoblastic leukemia.Rituximab in the management of acute lymphoblastic leukemia.Treatment of sporadic Burkitt lymphoma in adults, a retrospective comparison of four treatment regimens.Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers.Relapsed/refractory Burkitt lymphoma and HIV infection.The promising role of monoclonal antibodies for immunotherapy of the HIV-associated cancer, non-Hodgkin lymphoma.Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.Romidepsin alone or in combination with anti-CD20 chimeric antigen receptor expanded natural killer cells targeting Burkitt lymphoma in vitro and in immunodeficient mice.Frondoside A induces AIF-associated caspase-independent apoptosis in Burkitt lymphoma cells.A comprehensive flow-cytometry-based immunophenotypic characterization of Burkitt-like lymphoma with 11q aberration.Incidence and risk factors for relapses in HIV-associated non-Hodgkin-lymphoma as observed in the German HIV-related lymphoma cohort study.Incidence of intensive care unit admission, outcome and post intensive care survival in patients with diffuse large B-cell lymphoma.Comprehensive genomic characterization dissects the complex biology of a case of synchronous Burkitt lymphoma and myeloid malignancy with shared hematopoietic ancestry.Genetic differences between paediatric and adult Burkitt lymphomas.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspectiveManagement of Lymphomas: Consensus Document 2018 by an Indian Expert Group
P2860
Q30238965-BE7C61A0-1332-4550-AEA1-3125C110C779Q30240133-AD8D8E6F-199E-4288-93E9-E2DD9FC61705Q30243925-E3CC6427-EDF1-4533-95E2-949EF8CF496BQ35236068-8156FF7C-44F1-48D6-BAEC-F4C99DBE4553Q36931139-152551C6-E0C7-4010-8E6F-D7C490341964Q36989459-3E6381E5-DF1E-4A28-BA8F-F240FCA90981Q38428357-033E4038-B523-4E39-972F-D80A3DC3BF8FQ38465823-18DDEDCA-6C0F-4505-BEF7-BB4169C38BFDQ38640263-5DB5FCF0-1955-4D78-BBB0-FC36D399D914Q38722432-9158F136-ECF6-4CE6-BA60-87BDFD48BCA0Q38782141-0785E3D9-BBC2-41B6-BCEF-27399F9075E5Q38806478-9291CBAD-15AF-49DA-8CB6-1B8641414E08Q38813978-3CB1DF5A-E546-4A25-837E-8CA2D6DB89D9Q38822525-1458FB75-B5BD-4CA3-8674-E55984079E33Q38848737-A7259CEF-89EF-40C7-AF9B-ADC80073AFDAQ40690632-CC69E011-8507-45E9-AC7E-500EAAC1BDADQ41244407-DE243154-38BC-4007-8BBF-868E01DAE42EQ41663533-AA51F7E0-59B6-4CAD-BB66-EB6D5322BDFEQ42384621-9088F398-4106-4D84-A8C5-38867CC81FC6Q47196522-1D6CBBCF-F6C2-489A-AA6A-C4CB984EFC80Q47361098-26A3518F-4FE0-4C57-8BE2-C493E5D06AF0Q47368952-608EFFC8-2BEE-4992-8029-1802F1A90DB4Q47562321-C62C4EA1-FF88-4D83-82C3-252673D734C3Q47563526-5B875BE4-D345-432F-A1DF-5FF28C620162Q47571040-FE9B733E-F9BE-435B-B4CD-865AA1B5F35FQ47951320-B73D0DBB-AF4A-4A5A-AD92-86E81D83B91EQ48138574-8215F82F-E589-40BF-A5CB-75B7C8851A25Q48254769-850C6FB9-337B-4E1E-A806-B6055BC010EBQ50035090-2FE51CA9-115B-4E24-9F91-05F2DB3B9AF9Q51556801-EFFCD4C6-453F-472A-A39E-7E256C338954Q52547022-D07F5F34-7E8E-46D8-9D81-050828E01A05Q53174284-CF40812E-FB28-44E9-B0B0-1633E24E9F19Q55283747-CEA09F4A-7705-4532-94D5-866E659FD8DFQ57174502-70D3F3E5-B372-4BA4-90EF-7147207FC759Q58801965-A8B1E509-F4DC-4214-AF41-728F78F2CBB0
P2860
Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Improved outcome of adult Burk ...... prospective multicenter trial
@ast
Improved outcome of adult Burk ...... prospective multicenter trial
@en
Improved outcome of adult Burk ...... prospective multicenter trial
@nl
type
label
Improved outcome of adult Burk ...... prospective multicenter trial
@ast
Improved outcome of adult Burk ...... prospective multicenter trial
@en
Improved outcome of adult Burk ...... prospective multicenter trial
@nl
prefLabel
Improved outcome of adult Burk ...... prospective multicenter trial
@ast
Improved outcome of adult Burk ...... prospective multicenter trial
@en
Improved outcome of adult Burk ...... prospective multicenter trial
@nl
P2093
P2860
P50
P921
P1433
P1476
Improved outcome of adult Burk ...... prospective multicenter trial
@en
P2093
Albrecht Reichle
Andreas Viardot
Bernd Hertenstein
Dieter Hoelzer
Eckhard Thiel
German Multicenter Study Group for Adult Acute Lymphoblastic Leukemia
Harald Rieder
Heinz-August Horst
Ingo G H Schmidt-Wolf
Jan Walewski
P2860
P304
P356
10.1182/BLOOD-2014-03-563627
P407
P577
2014-10-30T00:00:00Z